2023
DOI: 10.14218/jcth.2022.00276
|View full text |Cite
|
Sign up to set email alerts
|

STX5 Inhibits Hepatocellular Carcinoma Adhesion and Promotes Metastasis by Regulating the PI3K/mTOR Pathway

Abstract: Background and Aims: Syntaxin 5 (STX5) is a member of the syntaxin or target-soluble SNAP receptor (t-SNARE) fam

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 42 publications
(41 reference statements)
0
2
0
Order By: Relevance
“…3B). Interestingly, the most significant positive relationships were seen to proteins with known roles in cancer progression and development: protein YIF1A 38 , ubiquitin associated protein 1 (UBAP1) 39 , DDRGK domain-containing protein 1 40 and syntaxin-5 (STX5) 41 . This is relevant to reports of poor glycemic control being associated with and increased risk of multiple cancers 42 .…”
Section: Resultsmentioning
confidence: 99%
“…3B). Interestingly, the most significant positive relationships were seen to proteins with known roles in cancer progression and development: protein YIF1A 38 , ubiquitin associated protein 1 (UBAP1) 39 , DDRGK domain-containing protein 1 40 and syntaxin-5 (STX5) 41 . This is relevant to reports of poor glycemic control being associated with and increased risk of multiple cancers 42 .…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, the most significant positive relationships were seen to proteins with known roles in cancer progression and development: protein YIF1A, 38 ubiquitin-associated protein 1 (UBAP1), 39 DDRGK domain-containing protein 1 (DDRGK1), 40 and syntaxin-5 (STX5). 41 Poor glycemic control is associated with increased risk of multiple cancers. 42 …”
Section: Resultsmentioning
confidence: 99%
“…Multiple oncogenic properties have been widely linked to the expression of SNARE proteins ( 49 ). Moreover, STX5 has been recently described to modulate PI3K/mTOR pathway activation, subsequently restraining cell adhesion and thus favoring metastasis in hepatocellular carcinoma ( 50 ). Although STX5-mediated pro-tumorigenic mechanisms in HGSOC remain to be elucidated, our results demonstrate that expression of STX5 in PFD-sEVs is associated with tumor progression and, to a lesser extent, with the degree of response to chemotherapy, which would be in line with analogous functions observed in other members of its protein family ( 49 ).…”
Section: Discussionmentioning
confidence: 99%